Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance
Mehrdad Hashemi, Sahar Hasani, Shima Hajimazdarany, et al.
International Journal of Biological Macromolecules (2022) Vol. 222, pp. 1151-1167
Closed Access | Times Cited: 20

Showing 20 citing articles:

Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Qingmiao Shi, Chen Xue, Yifan Zeng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 84
HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response
Mehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, et al.
Pharmacological Research (2023) Vol. 190, pp. 106732-106732
Open Access | Times Cited: 24
Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression
Raffaele Strippoli, Reyhaneh Niayesh‐Mehr, Maryam Adelipour, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 807-807
Open Access | Times Cited: 12
Comprehensive review for non-coding RNAs: From mechanisms to therapeutic applications
Yanjun Zhang, Lijuan Zhan, Xue Jiang, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116218-116218
Closed Access | Times Cited: 11
Therapeutic potential of TRPM8 channels in cancer treatment
Sara V. Ochoa, Zulma Casas, Sonia Luz Albarracín, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
Targeting notch-related lncRNAs in cancer: Insights into molecular regulation and therapeutic potential
Raihan Siddique, Gaurav Gupta, Johar MGM, et al.
Pathology - Research and Practice (2024) Vol. 257, pp. 155282-155282
Closed Access | Times Cited: 7
Notch signaling pathway: a new target for neuropathic pain therapy
Yan Zhang, Tingting Wang, Sanlan Wu, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 15
The Impact of TRPM8 on Prostate Cancer Transcriptomic Dynamics
Swapna Asuthkar, Susovon Bayen, Erick Benjamin Saldes, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 501-501
Open Access
Examining the contribution of Notch signaling to lung disease development
Samar Antar, Mohamed Kh. ElMahdy, Ahmed G. Darwish
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 9, pp. 6337-6349
Closed Access | Times Cited: 3
Thermodynamic and cellular studies of doxorubicin/daunorubicin loaded by a DNA tetrahedron for diagnostic imaging, chemotherapy, and gene therapy
Xinyu Li, Yushu Wu, Xinpeng Zhang, et al.
International Journal of Biological Macromolecules (2023) Vol. 251, pp. 126245-126245
Closed Access | Times Cited: 7
Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response
Mehrdad Hashemi, Padideh Daneii, Mohammad Arad Zandieh, et al.
Non-coding RNA Research (2023) Vol. 9, Iss. 1, pp. 84-104
Open Access | Times Cited: 7
Review on Long Non-Coding RNAs as Biomarkers and Potentially Therapeutic Targets for Bacterial Infections
Liqin Shi, Xueya Han, Fang Liu, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 7558-7576
Open Access | Times Cited: 2
Tenofovir alone or combined with doxorubicin abrogates DMBA-induced mammary cell carcinoma: An insight into its modulatory impact on oxidative/Notch/apoptotic signaling
Hadeer M. Abouelezz, Dalia H. El‐Kashef, Rania R. Abdеlaziz, et al.
Life Sciences (2023) Vol. 326, pp. 121798-121798
Closed Access | Times Cited: 4
A review of nuclear Dbf2-related kinase 1 (NDR1) protein interaction as promising new target for cancer therapy
Jiani Lu, Yanjun Feng, Danmei Yu, et al.
International Journal of Biological Macromolecules (2024) Vol. 259, pp. 129188-129188
Closed Access | Times Cited: 1
Role of the lncRNA/Wnt signaling pathway in digestive system cancer: a literature review
Penghui Li, Xiao Ma, Di Huang
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
The prospective potential of fluoroquinolones as anticancer agents
Rania AbuBaih, Michael Atef Fawzy, Maiiada Nazmy
Journal of Modern Research (2023) Vol. 5, Iss. 1, pp. 4-10
Open Access | Times Cited: 3
Celastrol can inhibit the growth of SHH medulloblastoma: In vitro and in vivo studies
薄鸿 王, 道 徐, 丽生 余, et al.
Research Square (Research Square) (2024)
Open Access
The TCONS_00046732/chi-miR-135b-5p/PRLR regulatory axis promotes endometrial epithelial cells growth through the PI3K-Akt signaling pathway
Yanyan Wang, Qing Li, Peipei He, et al.
International Journal of Biological Macromolecules (2024) Vol. 283, pp. 137248-137248
Closed Access
Exploring the clinical potential of circulating LncRNAs in breast cancer: insights into primary signaling pathways and therapeutic interventions
Tohada M. AL‐Noshokaty, Rehab Abdelhamid, Tasnim Reda, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 6
Closed Access
A critical review on cancer vaccines: a promising immunotherapy
Jaya Verma, Caaisha Warsame, Saurav Goel
Biomaterials and Polymers Horizon (2022) Vol. 1, Iss. 3
Open Access
Page 1

Scroll to top